D. Porter

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

J. Forbes, R. Gelber, G. Hortobagyi, 2015, The New England journal of medicine.

Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women’s Wellness After Breast Cancer (YWWACP) lifestyle intervention

D. Anderson, J. Porter-Steele, S. Benge, 2022, Pilot and Feasibility Studies.

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

J. Forbes, R. Gelber, G. Hortobagyi, 2015, The New England journal of medicine.

Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review

D. Porter, J. Elwood, S. Ioannides, 2014, Breast Cancer Research and Treatment.